EUVIMEDEUVIMED entdecken
Crossref

Rapid remission of severe impetigo herpetiformis following combined treatment with secukinumab and corticosteroids

Xiaotian Ni, Ming Liu

European Journal of Dermatology · 2023

DOI: 10.1684/ejd.2023.4620 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Dermatology, 2023. Verfasst von Xiaotian Ni und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Impetigo, Skin Diseases, Vesiculobullous, Pregnancy Complications, Infectious, Dermatitis Herpetiformis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BackgroundSarcoidosis is a systemic disease that affects the skin in about 25% of patients. The treatment of cutaneous sarcoidosis is guided by the extent of lesions, associated symptoms and organ involvement.ObjectivesTo evaluate rates of response to various potential first-line treatments for cutaneous sarcoidosis during the year following treatment initiation.Materials & MethodsThis retrospective multicentre study included 120 patients with cutaneous sarcoidosis. Treatment response was assessed retrospectively from the patients’ medical records. Univariate logistic regression analysis, with an estimation of unadjusted odds ratios (OR) and their 95% CI,was performed to identify factors associated with complete cutaneous remission (CR), followed by multivariate logistic regression analysis.ResultsAt one year, 43 of the 120 (36%) included patients had CR. The best response rates were obtained with oral corticosteroids (12/21, 57%), followed by a combination of hydroxychloroquine and topical steroids (6/13, 46%). In multivariate analysis, lupus pernio was the only predictor of a poor cutaneous response.ConclusionWe suggest the use of a combination of hydroxychloroquine and topical steroids as an optimal first-line treatment for cutaneous sarcoidosis, given the known adverse effects of systemic corticosteroids.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImpetigoSkin Diseases, VesiculobullousPregnancy Complications, InfectiousDermatitis HerpetiformisPregnancy ComplicationsPsoriasisAntibodies, Monoclonal, HumanizedHumansPregnancyFemaleAdrenal Cortex Hormones

Substanzen

secukinumabAdrenal Cortex HormonesAntibodies, Monoclonal, Humanized

Zitieren

APA

Ni, X., & Liu, M. (2023). Rapid remission of severe impetigo herpetiformis following combined treatment with secukinumab and corticosteroids. European Journal of Dermatology. https://doi.org/10.1684/ejd.2023.4620

Vancouver

Ni X, Liu M. Rapid remission of severe impetigo herpetiformis following combined treatment with secukinumab and corticosteroids. European Journal of Dermatology. 2023. doi:10.1684/ejd.2023.4620

BibTeX
@article{Ni2023,
  author = {Ni, Xiaotian and Liu, Ming},
  title = {Rapid remission of severe impetigo herpetiformis following combined treatment with secukinumab and corticosteroids},
  journal = {European Journal of Dermatology},
  year = {2023},
  doi = {10.1684/ejd.2023.4620}
}
Kostenlos starten →